Literature DB >> 15509506

Competitive repopulation assay of two gene-marked cord blood units in NOD/SCID/gammac(null) mice.

Takashi Yahata1, Kiyoshi Ando, Hiroko Miyatake, Tomoko Uno, Tadayuki Sato, Mamoru Ito, Shunichi Kato, Tomomitsu Hotta.   

Abstract

In multiunit cord blood transplantation, hematopoietic stem cells from each unrelated cord blood (UCB) unit competitively reconstitute the hematopoietic system in a recipient. To evaluate the fate of the progeny of each UCB unit and to determine the effects of graft-versus-graft reaction, we established a novel competitive repopulation assay using NOD/SCID/gammac(null) mice in which human T lymphocytes develop from CD34+ cells. CD34+ cells from each UCB unit were labeled with recombinant lentivirus vectors carrying genes encoding either enhanced green fluorescent protein (EGFP) or enhanced yellow fluorescent protein (EYFP). Hematopoietic chimerism composed of both EGFP+ and EYFP+ cells was stably maintained up to 6 months after transplantation with purified CD34+ cells; the ratio of EGFP+ to EYFP+ cells in peripheral blood and bone marrow posttransplantation was equivalent to the ratio of these cells at transplantation. However, when mononuclear cells from two UCB units were cotransplanted with CD34+ cells, engraftment was highly competitive, with cells from only one or the other of the two UCB units surviving. Further subfractionations of mononuclear cells indicate that the skewed chimerism that is often observed in clinical multiunit cord blood transplantation may be mediated by the cooperation of both CD4+ and CD8+ T cells. The assay established here will be a useful tool for analyzing hematopoietic reconstitution in clinical multiunit cord blood transplantation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509506     DOI: 10.1016/j.ymthe.2004.07.029

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  10 in total

1.  HLA mismatch direction in cord blood transplantation: impact on outcome and implications for cord blood unit selection.

Authors:  Cladd E Stevens; Carmelita Carrier; Carol Carpenter; Dorothy Sung; Andromachi Scaradavou
Journal:  Blood       Date:  2011-07-12       Impact factor: 22.113

2.  An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment.

Authors:  Lamis K Eldjerou; Sonali Chaudhury; Ada Baisre-de Leon; Mai He; Maria E Arcila; Glenn Heller; Richard J O'Reilly; Juliet N Barker; Malcolm A Moore
Journal:  Blood       Date:  2010-06-29       Impact factor: 22.113

Review 3.  Graft predominance after double umbilical cord blood transplantation: a review.

Authors:  Jan J Cornelissen; Burak Kalin; Cor H J Lamers
Journal:  Stem Cell Investig       Date:  2017-05-26

Review 4.  An overview of the progress on double umbilical cord blood transplantation.

Authors:  Anastasia Sideri; Nikolaos Neokleous; Philippe Brunet De La Grange; Bernadette Guerton; Marie-Caroline Le Bousse Kerdilles; Georges Uzan; Corina Peste-Tsilimidos; Eliane Gluckman
Journal:  Haematologica       Date:  2011-05-05       Impact factor: 9.941

5.  Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia.

Authors:  Andromachi Scaradavou; Claudio G Brunstein; Mary Eapen; Jennifer Le-Rademacher; Juliet N Barker; Nelson Chao; Corey Cutler; Colleen Delaney; Fangyu Kan; Luis Isola; Chatchada Karanes; Mary J Laughlin; John E Wagner; Elizabeth J Shpall
Journal:  Blood       Date:  2012-12-09       Impact factor: 22.113

6.  Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation.

Authors:  Michael A Brehm; Amy Cuthbert; Chaoxing Yang; David M Miller; Philip DiIorio; Joseph Laning; Lisa Burzenski; Bruce Gott; Oded Foreman; Anoop Kavirayani; Mary Herlihy; Aldo A Rossini; Leonard D Shultz; Dale L Greiner
Journal:  Clin Immunol       Date:  2010-01-21       Impact factor: 3.969

7.  Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.

Authors:  Jonathan A Gutman; Cameron J Turtle; Thomas J Manley; Shelly Heimfeld; Irwin D Bernstein; Stanley R Riddell; Colleen Delaney
Journal:  Blood       Date:  2009-10-12       Impact factor: 22.113

8.  Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft.

Authors:  John E Wagner; Claudio G Brunstein; Anthony E Boitano; Todd E DeFor; David McKenna; Darin Sumstad; Bruce R Blazar; Jakub Tolar; Chap Le; Julie Jones; Michael P Cooke; Conrad C Bleul
Journal:  Cell Stem Cell       Date:  2015-12-05       Impact factor: 24.633

9.  Niche displacement of human leukemic stem cells uniquely allows their competitive replacement with healthy HSPCs.

Authors:  Allison L Boyd; Clinton J V Campbell; Claudia I Hopkins; Aline Fiebig-Comyn; Jennifer Russell; Jelena Ulemek; Ronan Foley; Brian Leber; Anargyros Xenocostas; Tony J Collins; Mickie Bhatia
Journal:  J Exp Med       Date:  2014-09-01       Impact factor: 14.307

10.  Multiple allogeneic progenitors in combination function as a unit to support early transient hematopoiesis in transplantation.

Authors:  Takashi Ishida; Satoshi Takahashi; Chen-Yi Lai; Masanori Nojima; Ryo Yamamoto; Emiko Takeuchi; Yasuo Takeuchi; Masaaki Higashihara; Hiromitsu Nakauchi; Makoto Otsu
Journal:  J Exp Med       Date:  2016-08-08       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.